When the aortic root—the section of the aorta attached to the heart—becomes aneurysmal, surgery is often necessary.
Transcatheter Aortic Valve Replacement (TAVR) is no longer just for high-risk patients. It has become a standard for aortic stenosis across all risk levels. Recent updates include: Advances in Treatments for Aortic Valve and Roo...
: With more younger patients (under 65) receiving TAVR, focus has shifted to "redo TAVR" and ensuring the first valve choice allows for future interventions. 2. Innovations in Aortic Root Surgery When the aortic root—the section of the aorta
: Guidelines in 2025 increasingly support TAVR for asymptomatic patients, as studies show that early replacement can prevent future heart failure hospitalizations. Recent updates include: : With more younger patients
: While TAVR was originally for narrowed valves, new devices like the JenaValve and J-Valve use specialized locator prongs to anchor into leaky valves that lack calcium.
Advances in Treatments for Aortic Valve and Root For decades, the standard for a diseased aortic valve or root was major open-heart surgery, often requiring lifelong blood thinners. However, 2025 has brought a wave of innovations that are making treatments less invasive and more tailored to individual patients. From new devices for leaky valves to AI-driven surgical planning, the "next frontier" of cardiac care is here. 1. The Transcatheter Revolution Expands